Prognostic value and therapeutic consequences of vascular invasion in non-small cell lung carcinoma
Introduction
As many as 60–80% of non-small cell lung carcinomas (NSCLC) are already inoperable at the time of diagnosis [1], [2]. In stages IA–IIB, resection is still the treatment of choice [3]. Stage IA tumors (T1/N0) are associated with a 5-year survival of more than 70% [4], [5]. Lymph node status is often quoted as the most important prognostic factor [5], [6], [7], [8], [9], [10], [11], but other parameters, such as UICC stage, histology, grade, and residual tumor status (R classification), are also important prognostic factors [1], [3], [5], [11], [12], [13], [14]. However, it remains unclear whether intratumorous lymphatic invasion and/or blood vessel invasion (BVI) can be regarded as true prognostic factors [11], [15]. The aim of this study was to investigate the influence of early lymphatic tumor spread (only one regional lymph node positive) and BVI on the prognosis of patients with NSCLC, mainly in stages IIA–IIIA, and their possible consequences for the choice of treatment.
Section snippets
Patients and material
The study was performed on 112 carefully selected patients who had had potentially curative surgery for an NSCLC between 1994 and 2003. In all cases, systematic lymph node dissection revealed metastasis to only one regional lymph node, the earliest stage of lymphatic metastasis.
All the surgical specimens were processed in the Institute of Pathology in Leonberg (Germany). Biopsy specimens obtained during preliminary investigations and in the later course of the disease enabled the morphological
Patients: clinical data and tumor profile
Table 1 shows the clinical data of the 112 patients and the anatomical and histological details of the tumors at the time of operation. The findings are consistent with those cited in the literature and can thus be considered typical. There were more squamous cell carcinomas (47.3%) than adenocarcinomas (30.3%), large cell carcinomas (15.2%), pleomorphic carcinomas (6.3%) and one case of adenosquamous carcinoma (0.9%). The most common macroscopic growth pattern was the scirrhous stenosing type
Discussion
The course and prognosis of primary NSCLC were investigated in 112 patients who had undergone potentially curative tumor resection and systematic lymphadenectomy between 1994 and 2003. All the patients exhibited early lymphatic metastasis, only one regional lymph node being involved (pN1 or pN2). This cannot necessarily, however, be considered to represent the early stage of the disease process if the years of tumor growth before diagnosis are considered. Tumors generally associated with a
Conclusions
Histologically confirmed BVI is a significant prognostic factor in NSCLC, and the patients represent a high-risk group. Adjuvant mediastinal radiation in node-positive cases may prevent local recurrence but is unlikely to influence the development of distant metastasis even in early-stage tumors. BVI should be considered for inclusion in the staging criteria and indications for adjuvant chemotherapy.
Conflict of interest
None of the authors have any actual or potential conflicts of interest in connection with the paper.
Acknowledgement
Mrs. C. Laberke is acknowledged for writing assistance.
References (44)
- et al.
Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience
Ann Thorac Surg
(2001) - et al.
Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer
Ann Thorac Surg
(1996) - et al.
Lymph node mapping and curability at various levels of metastasis in resected lung cancer
J Thorac Cardiovasc Surg
(1978) - et al.
Histological determinants of survival in completely resected T1-2N1MO nonsmall cell cancer of the lung
Ann Thorac Surg
(2004) - et al.
Prognostic significance of N1 disease in carcinoma of the lung
J Thorac Cardiovasc Surg
(1983) - et al.
Where is the boundary between N1 and N2 stations in lung cancer?
Ann Thorac Surg
(2000) - et al.
Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer. An analysis in each pathologic stage
J Thorac Cardiovasc Surg
(1995) - et al.
Stage IA non-small cell lung cancer: Vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy
Lung Cancer
(2007) - et al.
Chirurgische Onkologie
(2002) - et al.
Atlas of tumor pathology. Fasc. 13. Tumors of the lower respiratory tract
(1995)